Merck Serono, as part of a planned restructuring program, will close its facilities headquartered in Geneva, Switzerland and consolidate all functions in one Merck Serono Campus in Darmstadt, Germany. Of the 1,250 positions in Geneva, more than 750 positions will be transferred and 500 positions will be eliminated. Key R&D positions will be transferred from Geneva to Darmstadt, Boston (USA) and Beijing (China) in an effort to leverage scientific expertise in the biotech hub of Boston and to ...